Long-Term Safety of Febuxostat in Subjects With Gout.
NCT00174941
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
116
Enrollment
INDUSTRY
Sponsor class
Conditions
Gout
Interventions
DRUG:
Febuxostat
DRUG:
Febuxostat
DRUG:
Febuxostat
Sponsor
Takeda